COVID-19 news
This week
Latest WHO situation reports
Coronavirus disease (COVID-19) weekly epidemiological and monthly operational updates
who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports
to hide list)
25 October 2021 - Listening & Learning podcast series
Tune in to hear how immunization professionals around the globe have responded to the COVID-19 pandemic. Visit bit.ly/3lTeFNx to listen to the latest episodes.
Episode 1: Lessons from the Frontline: COVID-19 Mass Vaccination
This episode dives into the practical, tactical, and technical aspects of setting up and implementing mass vaccination sites. With insights from the frontline vaccine delivery team Curative and the World Health Organization (WHO), the episode offers insights on how to prepare frontline healthcare workers to ensure timely and efficient delivery of COVID-19 mRNA vaccines.
Episode 2: Pivoting in the Pandemic: Vaccine Research to Vaccination Practice
This episode shares lessons from the Sisonke Study, a phase 3B open label study that provided pre-emergency use access to the Johnson and Johnson vaccine to health workers in South Africa. Researchers share scientific, regulatory, and ethical considerations needed to move rapidly from a clinical trial setup to active vaccination sites.
Episode 3: Preparing for COVID-19 Vaccines Deployment: Guidelines & Insights for Healthcare Workers
This episode features an interview with Ann Lindstrand, the Unit Head for the Essential Programme on Immunization at WHO. Dr Lindstrand answers specific questions from the Boost Community around vaccine efficacy, hesitancy, and equity particularly around COVID-19 mRNA vaccines, and provides insights on how WHO is supporting the global vaccine roll-out.
COVID-19 news from WHO: 28 July 2021
New COVID-19 vaccine resources
With an expected vaccine delivery ramp-up and uptake surge in the next months, coordination and preparedness will be key to ensure the maximal use of COVID-19 vaccines. Countries are encouraged to update their national deployment and vaccination plans and costing through the Partners Platform, which will help access needs and resource gaps - including delivery costing - in preparation for vaccine roll-out. The COVAX Country Readiness and Delivery workstream is finalizing guidance and tools to support preparedness.
Please see below some recently published updates to the COVID-19 vaccine introduction toolkit, which is available in AR CH EN FR RU SP.
New guidance
The updated Guidance on Developing a National Deployment and Vaccination Plan for COVID-19 vaccines (2.0) is available online, with new information on a number of areas, including updated additional resources at the end of each chapter.
Vaccines costing and funding
New resources on vaccines costing and funding aim to facilitate national deployment and vaccination plans submission, including a pre-populated version of the COVID-19 Vaccine Introduction and deployment Costing tool (CVIC tool): CVIC 2.2 EZ tool for AMC92 countries, with most of the input cells pre-filled with global estimates.
The COVID-19 vaccination costing Q&A provides a basic introduction to the importance of a good costing exercise for COVID-19 vaccine roll-out, how it can be done, and how to seek technical assistance.
"What is the CVIC tool?" video is available in English, French and Spanish.
The OpenWHO course CVIC tool: using the COVID-19 Vaccine Introduction and deployment Costing Tool targets national programme managers and personnel who have been involved in the costing, budgeting or financing processes of COVID-19 vaccine delivery at the country level.
Technical support on the use of the CVIC tool is available. The World Health Organization (WHO) Costing Team can be reached at: CVICosting@who.int.
No-fault compensation
The COVAX No-Fault Compensation Program webpage brings more information on NFC for Advance Market Commitment (AMC) Eligible Economies. The Program provides fair, no-fault, lump sum compensation to eligible individuals who suffer certain serious adverse events after receiving vaccines distributed through the COVAX Facility until 30 June 2022.
COVAX No-Fault Compensation Program for AMC-Eligible Economies
Target populations and delivery strategies
The WHO SAGE roadmap for prioritizing uses of COVID-19 vaccines in the context of limited supply: An approach to inform planning and subsequent recommendations based on epidemiological setting and vaccine supply scenarios, first issued on 20 October 2020, was recently updated considering epidemiological settings and vaccine supply scenarios.
Also check out the Guidance note and checklist for tackling gender-related barriers to equitable COVID-19 vaccine deployment.
LEARN HOW TO INTRODUCE COVID-19 VACCINES
New and updated resources
These resources inform vaccine deployment considering supply constraints:
Guidance on utilization of COVID19 vaccine before the date of expiry
Vaccine safety
Check out the Vaccine safety poster for health workers on how to monitor and report COVID-19 vaccine side effects.
The recognizing anaphylaxis training video provides a brief overview on how to recognize anaphylaxis versus an immunization stress-related response, and the identifying and managing anaphylaxis training video explains how to manage anaphylaxis.
Also available online:
Vaccine effectiveness
NEW Addendum: Guidance on Conducting Vaccine Effectiveness evaluations in the setting of new SARS-CoV-2 variants. This resource addresses specific issues to consider when evaluating COVID-19 vaccine effectiveness using observational study designs in the setting of new SARS-CoV-2 variants.
Training opportunities
Please join the WHO Costing, Budgeting, Financing and Delivery of COVID-19 Vaccines webinars, with interpretation into French and Spanish.
Upcoming sessions:
- July 28: COVID-19 Vaccination: Costing for scale-up (15:00 - 16:30 CET)
- Aug 25: Financing alone is not enough - planning & executing on the budget (12:00 - 13:00 CET)
Mini-cPIE (COVID-19 vaccination IAR) Clinic 1
Join the experience sharing clinic on how countries are reviewing their COVID-19 vaccine roll-out through WHO COVID-19 vaccination intra-action review (IAR), also known as mini-cPIE.
When: 28 July 12:30-1:30 pm CET with interpretation into French and Spanish.
Have questions or suggestions?
Consultation on COVID-19 vaccines research
When: 13 August, 1:00-5:00 pm CET
The objective of this consultation is to review the available evidence on the efficacy and effectiveness of COVID-19 vaccines being deployed in terms of:
- Emerging variants effect on protection levels
- Duration of protection
- Safety of booster vaccines
- Research to evaluate various delivery strategies
Call for experts
The WHO is inviting anyone interested in serving on the Strategic Advisory Group of Experts (SAGE) on Immunization to consider applying for inclusion on the newly established SAGE Roster. This call seeks to identify candidates that can be retained in a roster of experts from which a selection for new SAGE members could take place as the need arises.
Deadline for applications: 10 Sep 2021
COVID-19 news from WHO: 21 May 2021
New COVID-19 vaccine resources
As we gear towards the 74th World Health Assembly, which will take place virtually from 24 May to 1 June 2021 in light of the ongoing COVID-19 pandemic, we reflect on the progress made in terms of vaccines introduction and roll-out. More than 120 COVAX participants have now received at least one shipment of COVID-19 vaccines, with over 58.2 million doses delivered as of 11 May. These achievements were only possible due to the unwavering commitment by partners and immunization professionals around the world.
Please see below some recently published updates to the COVID-19 vaccine introduction toolkit, which is available in AR CH EN FR RU SP.
LEARN HOW TO INTRODUCE COVID-19 VACCINES
The COVID-19 Vaccine Introduction and deployment Costing Tool (CVIC tool) supports credible COVID-19 vaccination costing to facilitate a dialogue with stakeholders, while maintaining sensitivity to protecting essential health services. It provides a structured and comprehensive estimation of incremental operational and selected capital costs of introducing and deploying COVID-19 vaccines, in alignment with the National Deployment and Vaccination Plan (NDVP). This is essential for resource mobilization, budgeting, and delivery strategy refinement and optimization.
The tool has been pre-populated with data from global databases and provides a total cost estimate for an immunization programme over the period of 2021-2023, after which COVID-19 vaccination is expected to be integrated into national immunization plans.
Countries can customize the priority target populations based on the WHO SAGE guidance and select multiple delivery strategies and vaccine products. The tool is available in all six UN languages (Arabic, Chinese, English, French, Russian and Spanish) and Portuguese.
Countries can submit their resource needs onto the WHO COVID-19 Partners Platform by either uploading a completed CVIC 2.1 tool excel spreadsheet or manually entering their resource needs. The cost categories for technical assistance and funding resource requests through the platform are harmonized into the nine common costing categories outlined in the NDVP Guidance 2.0.
No-fault Compensation Program
The COVAX No-Fault Compensation Program for AMC-Eligible Economies (the “Program”) has been operational since 31 March 2021. The Program’s Protocol (procedure) and Forms - including application and other forms - as well as other relevant Program information and resources are available in English, French and Spanish on the Program’s web portal, which also has instructions on how to submit an application and detailed FAQs to guide interested applicants.
ESIS Inc. will not charge any fees to Program applicants. Eligible individuals will have ample time to apply for compensation under the Program including if a COVAX-distributed vaccine was administered to them before the Program became operational on 31 March 2021.
COVAX No-Fault Compensation Program for AMC-Eligible Economies
Vaccine specific updates
The AstraZeneca vaccine explainer has been updated according to Emergency Use Listing and SAGE recommendations.
The short Janssen vaccine instructional video and the training video on how to identify and manage anaphylaxis are now available online.
Have questions or suggestions?
Extra doses in a vial
Please check out the job aide that explains Why are there extra doses of vaccine in the vaccine vial and provides guidance for their use. Currently available in: AR CH EN RU SP.
Supportive supervision
You can review the Supportive supervision for COVID-19 vaccination job aide, now available in AR CH EN FR.
Communication flow
The communications flow diagram has been updated and now includes key messaging for pregnant women.
Intra-action review
Intra-action review (also known as the mini COVID-19 Post Introduction Evaluation, or mini-cPIE) documents trigger question database, note taking template, and report template are available in English.
Learn how to use these tools watching the Mini-cPIE (COVID-19 vaccination IAR) - What is it and how to conduct one training, in EN FR RU and SP.
Check out the slide set, available in English.
Training opportunities
Three more sessions remain for the national/sub-national audience of the COVID-19 Vaccination: Building Global Capacity webinars (Tuesdays, 12:00 - 13:00 CET), with live interpretation into French and Spanish.
Upcoming sessions:
- 18 May - Private Sector Engagement
- 1 June - Monitoring and Evaluating COVID-19 Vaccine Introduction
- 15 June - Adaptive leadership for COVID-19 Vaccine Introduction
Register for upcoming ECHO sessions here
Calling all volunteers
Do you work on health or immunization? Are you passionate about new and innovative approaches to improving vaccination coverage? If ‘yes’, then we’d like to hear from you!
WHO has developed a set of tools to support immunization programmes with the roll-out of COVID-19 vaccines and routine immunization strengthening. We are seeking critical and innovative thinkers to test these tools through telephone interviews in Angola, Ethiopia, India, Nigeria and Pakistan.
In partnership with research expert Kantar Public, WHO is looking to interview health professionals, programme managers, health officers and community volunteers involved in planning, delivering and/or advocating for immunization. Register your interest here! Please feel free to share this email with others who may be eligible and interested.
This work is part of a long-standing initiative to develop globally validated tools that support programmes to assess and address the social and behavioral drivers of immunization. This is a multi-partner initiative funded by Gavi and the Bill and Melinda Gates Foundation. If you’d like to hear more about this work, please do not hesitate to email Francine Ganter-Restrepo: ganterf@who.int.
Protection against violence
COVID-19 news from FIRS: 31 March 2021
The Forum of International Respiratory Societies: For the health of everyone, equitable access to COVID-19 vaccines is urgently and quickly needed in all countries
31 March 2021 – An article launched today by the Forum of International Respiratory Societies (FIRS), an organisation comprised of the world's leading international respiratory societies, highlights COVID-19 efficacy and safety and calls for urgent equitable access in all countries.
The speed of development of effective vaccines for COVID-19 has been unprecedented, with several now widely available and in use. COVID-19 vaccination is one of the most pressing global issues. Vaccines are being distributed in more than 85 countries, with cumulatively more than 200 million doses administered globally. However, vaccination is predominantly occurring in high income settings while in many low- and middle-income countries, vaccination has not started or is occurring in very small numbers.
Priority for vaccination should be given to health workers, followed by those who are most vulnerable to develop severe disease and those who are most exposed to infection.
Inequities in global access to vaccination have exposed and worsened large disparities between countries. Countries with the lowest rates of vaccination are also those with the most fragile health systems, lack of infrastructure for widespread vaccination programmes, lack of access to oxygen and other lifesaving interventions and more economically disadvantaged populations. Greater co-operation and collaboration between high-income countries, donor foundations, vaccine manufacturers and low- and middle-income countries is needed to ensure access to vaccines on a not-for-profit basis, equitable distribution, and sustained programmes to ensure vaccination.
“Vaccines against COVID-19 are a key complimentary intervention to bring the pandemic under control globally. For the health of everyone, equitable access to COVID-19 vaccines is urgently and quickly needed in all countries.” said Mark Cohen, President of FIRS.
The article also explores COVID-19 vaccine efficacy and the rigorous safety standards that have been met.
Vlick this link to open the FIRS Vaccine Equity full article.
Click the square image on the right and download for your Facebook and Instagram posts, and the rectangular image for your Twitter post.
COVID-19 news from WHO: 30 March 2021
Dear colleague,
The COVID-19 vaccine introduction toolkit is now available in all UN languages: Arabic, Chinese, French, Russian and Spanish. We will update these pages as more resources become available. For questions, comments or feedback, please e-mail: COVID19vaccineresources@who.int.
Please check out these new resources added to the Toolkit to support COVID-19 vaccination:
COVID-19 Vaccine Specific Resources
- The OpenWHO COVID-19 vaccine-specific resources course is now available in EN, CH, RU.
You can also watch the videos from the COVID-19 vaccine specific resources course on how to handle, prepare, and administer COVID-19 vaccines here: - The Janssen (Johnson and Johnson) vaccine explainer is now available.
- Considerations for optimizing deployment of AstraZeneca/AZD1222 and SII/Covishield vaccines in a time-limited constrained supply situation provides an overview of programmatic considerations to guide national decision-making.
COVID-19 Vaccine Effectiveness Guidance
- Vaccine effectiveness and impact guidance and its accompanying sample size calculator provide interim guidance on how to assess COVID-19 vaccine effectiveness. It discusses critical considerations in the design, analysis and interpretation of vaccine effectiveness evaluations to avoid biased results.
COVID-19 Vaccination Capacity Training Resources
- The Health Worker COVID-19 Vaccination course is now available in various languages: AR, CH, EN, FR, RU, SP and also in Dutch, Indonesian, Macedonian and Vietnamese. If you’d like to request access to the presentations, please email COVID19vaccineresources@who.int.
- The COVID-19 immunization checklist, an important job aid for health workers,is also available in new language versions. AR, EN, FR, RU, SP, PT.
- The COVID-19 Vaccination: Building Global Capacity webinars continue every Tuesday from 12:00 to 13:00 CET (interpretation into French and Spanish). Webinar materials are available through TechNet-21. For registration links and additional resources, please visit the Project ECHO website.
| Date | Audience | Topic | Registration |
| 30 Mar | Health Workers | Reporting on COVID-19 vaccines (monitoring and AEFI) | echo.zoom.us/webinar/register/WN_ 81Wgk82kRcmmMVJ43SNOuA |
| 06 Apr | National/Subnational | Vaccination strategies for COVID-19 vaccination | echo.zoom.us/webinar/register/WN_ 60QBnRtURmaoXz2mGFWPIQ |
| 13 Apr | Health Workers | Supply and logistics | echo.zoom.us/webinar/register/WN_ 81Wgk82kRcmmMVJ43SNOuA |
| 20 Apr | National/Subnational | Mobilizing financing resources to scale-up COVID-19 vaccination | echo.zoom.us/webinar/register/WN_ 60QBnRtURmaoXz2mGFWPIQ |
Covid-19 vaccine update from WHO: 17 March
Dear Colleagues
Please note that TPs [Talking Points] regarding various European countries suspending batches or temporarily halting the use of the AstraZeneca vaccine, are available. As this is an ongoing topic please contact Kate Thompson (thompsonk@who.int) for the latest TPs.
Due to concerns about the size of the talking points document, some sections of previously cleared language have been moved into an annex. [See annex at apsresp.org/archive/covid-19/who-20210317-annex.docx]
Revisions & updates to the content are highlighted grey. Substantive revisions have been made to:
- Threat of COVAX being sued
- Black market usage of vaccines and/or packaging
- Vaccine passports
- Reactive statements to news stories: EU blocking exports & reports of adverse events following immunisation.
We know there are gaps in the talking points and are working on developing TPs on the below topics
- Vaccine pricing
- Supporting national authorisation after EUL
COVID-19 Vaccine Digital Content:
COVID-19 DIGITAL CONTENT UPDATE – has a section that features new vaccine content. Sign up here.
Please read and share this series of explainers on vaccines (each web page links to “resources” where you will find assets in various formats, languages and editable art files for your adaption and use):
[The links below are in English. For other languages, please see the WHO webpage here.]
- How do vaccines work?
- How are vaccines developed?
- Manufacturing, safety and quality control of vaccines
- The different types of COVID-19 vaccines
- How will there be fair and equitable allocation of limited supplies?
- Country readiness for COVID-19 vaccines
- NEW: The effects of virus variants on COVID-19 vaccines
NEW: All Vaccines Explained content
- Science in 5 #24 Vaccine myths vs Science
- Science in 5 #25 Vaccine Explained (Children & those who have had covid infection before)
- Science in 5 #26 Vaccine dosage
- NEW: Science in 5 #27 Vaccines, Variants and Herd Immunity
- Gallery: WHO COVID-19 Photo Gallery
- Gallery: COVID-19 vaccination in the United Kingdom
- NEW Gallery: COVAX vaccinations arrive in Moldova
- NEW Gallery: COVAX vaccinations arrive in Nepal
- NEW Gallery: COVAX allocated vaccinations in Ghana
- New Video B-roll Vaccination preparations in El Salvador
- Statement: Joint statement by DG & UNICEF ED
- OP-ED: Vaccine nationalism harms everyone
- NEW: OP-ED:A ‘me first’ approach to vaccination won’t defeat Covid
- Campaign: #VaccinEquity declaration Twitter thread
- Video: Mixing and matching vaccines YouTube
- Video: How mRNA vaccines work YouTube
- Video: Should people who have already had Covid-19 still get vaccinated? YouTube
- Video: Will Covid-19 vaccines work against virus variants? YouTube
- Video: Should people with underlying conditions be vaccinated against Covid-19 vaccines YouTube
- Video: How the Pfizer/BioNTech vaccine should be used YouTube
- Video: Covid-19 Vaccines - What we need to know? YouTube
- Video: Journey of a vaccine - the cold chain Facebook; YouTube; Download
- Video: The road to a COVID-19 vaccine Facebook; YouTube; Download
- NEW Video: COVAX deliveries and campaigns begin around the world YouTube
- LIVE Q&A: about the safety of vaccines, diagnostics & therapeutics
- Explainer: Allocation Mechanism for COVAX Facility Vaccines
- Explainer: Allocation algorithm for COVAX Facility Vaccines
- WHO Dashboard NEW: now includes vaccination delivery data
- NEW:UNICEF Dashboard
All Covid-19 Vaccine information
COVID-19 vaccine country readiness and delivery
The COVID-19 vaccine acceptance and demand package
COVID-19 vaccine-specific resources
Pfizer
- What you need to know
- Vaccine explainer
- Instructional training video
- SAGE Interim recommendations for use of the Pfizer vaccine
- Training slide deck
Moderna
- What you need to know
- Vaccine explainer
- SAGE Interim recommendations for use of the Moderna mRNA-1273 vaccine against COVID-19
AstraZeneca
- What you need to know
- Vaccine explainer
- SAGE Interim Recommendations for use of the AZD1222 Vaccine against COVID-19
NEW:Johnson & Johnson
Technical guidance
COVID-19 vaccine country readiness and delivery
The COVID-19 vaccine demand package includes guidance, tools, and templates to generate acceptance and demand for COVID-19 vaccines.
- Acceptance and demand for COVID-19 vaccines: Guidance for overall planning
- Acceptance and demand for COVID-19 vaccines: Planning template in Excel
- Achieving high uptake of COVID-19 vaccines through measuring behavioral and social drivers
- Conducting community engagement for COVID-19 vaccines
- COVID-19 vaccines misinformation management guide
- COVID-19 vaccine introduction toolkit
- Health worker communication for COVID-19 vaccination flow diagram
COVAX specific resources
Diane Abad-Vergara
Communications Officer
Department of Communications
World Health Organization
Geneva, Switzerland
Office: +41 (0)22 791 2183
Mobile: +41 (0)79 200 5878
Web: who.int
Covid-19 vaccine update from WHO: 15 March
The WHO have asked us to share a copy of their Talking Points, a 45-page Word file you can see at apsresp.org/archive/covid-19/who-20210317.docx
Here are the main section headings and some related questions. Comprehensive answers are given in the Talking Points document.
- COVAX and equitable access
- Vaccine Quality and Safety
- Vaccine distribution
- Facts and figures at a glance
- The COVAX Pillar funding needs
- WHO’s work on vaccines
- Development of target product profiles and clinical trial advice
- Regulatory and policy
- Global mapping of vaccines in development
- Fair allocation framework - FAQs
- Why did some countries receive COVAX delivery earlier than others?
- When will the next allocation round begin?
- Billions of COVID-19 vaccines doses will be needed in the coming months and vaccines are likely to appear with different efficacy levels. How will decisions be made as to which countries receive which vaccines?
- What does an effective vaccine rollout strategy look like? How important is it to have a good reporting system?
- Is COVAX concerned about changes to supply timelines due to demand from countries bilateral agreements with manufacturers?
- Response to questions about the threat of Covax being sued
- WHO position on teachers being vaccinated
- What will happen if there is more than one vaccine to allocate?
- EUL and PQ process - FAQs
- Response to criticism that the WHO is slow to regulate vaccines from China & Russia
- Questions on Countries allowing vaccines before EUL & SRA
- Why did it take so long for WHO to assess AZ vaccine?
- What is the difference between the EUL process and SAGE?
- Vaccine rollout and distribution - FAQs
- Why are there two AstraZeneca/Oxford vaccine needing EUL & separate agreements with COVAX?
- SAGE policy recommendations for priority population groups
- Relating specifically to Pfizer/BioNTech vaccine, the WHO interim recommendations (based on SAGE ). Assessed 5th January 2021:
- Relating specifically to Oxford/AstraZeneca vaccine, the WHO interim recommendations (based on SAGE). Assessed 8th February 2021
- Relating specifically to Moderna vaccine, the WHO interim recommendations (Based on SAGE). Assessed 21st January 2021.
- What is WHO response to French authorities recommending only one shot for people who have had the COVID-19 infection?
- Supporting national authorization after WHO EUL
- Supporting post-authorization safety monitoring, impact and implementation
- Country readiness and delivery
- Manufacturing and vaccine distribution - FAQs
- Has WHO heard of any black market usage of the COVID vaccine (such as refilling vials and selling them 'privately') or whether this is something that WHO have deemed a risk.
- How does the WHO and the global community prepare for such issues surrounding the medical black market with regards to Covid-19?
- Scale up of manufacturing capacity - FAQs
- Does the WHO believe that the 20% target for 2021 is still realistic given current issues with scaling up manufacturing?
- Why is there a vaccine “shortage”?
- COVAX
- What is COVAX?
- 2.2 COVAX R&D work
- COVAX Facility
- The COVAX vaccine portfolio
- When will we have the vaccine and return to “normal life”?
- WHO positions on:
- Access and distribution
- Vaccine nationalism - FAQs
- Dr Tedros referred to countries bilateral deals which are undermining COVAX in a recent speech. Which countries are these?
- What seems to be happening currently, is that rich countries are buying what little vaccine doses are available with vague assurances that they will share doses in the future with poorer countries. How does WHO think this can be addressed?
- Is Vaccine nationalism undermining COVAX/Making it a failure?
- Why were Canada and other rich countries included in the COVAX interim allocation of countries?
- On why rich countries don’t have to complete an NVDP (reactive)
- Vaccine safety – how can we trust the rushed process?
- Is the Pfizer/BioNTech vaccine safe?
- Are we seeing worse side effects from the Pfizer/BioNTech vaccine compared with vaccines for other diseases? Is this something to be concerned about?
- In response to the concerns about AstraZeneca’s vaccine efficacy - will COVAX continue to distribute the AZ vaccine?
- In response to concerns about Sinovac vaccine after reports of illness after inoculation
- Are you concerned that COVAX is shipping vaccines that are already out-dated?
- Safety and efficacy for different population groups
- Pregnancy
- Claims about the vaccine leading to female infertility
- Inclusion of in people with mental illness in high-priority category for vaccination
- Claims people died after taking the Pfizer vaccine - how can we verify?
- Claims that COVID-19 vaccines are not Halal
- Norway
- Effect of Alcohol on efficacy
- Variant strains
- B.1.1.7
- B1.351
- P.1
- Impact on vaccines
- What is WHO’s response to the UK variant strain?
- Adverse effects following immunization - FAQs
- Are reports of allergic reactions Pfizer-BioNTech’s Covid-19 vaccine cause for concern?
- What is WHO’s advice for people who may have a history of allergic reactions; should they get the vaccine?
- How will the public know if they are having side-effects caused by the vaccine?
- Does WHO support setting up an apparatus within countries to respond to people who are experiencing an adverse reaction?
- Are there concerns that different population groups (eg different sexes, ethnicities and morbidities) could be afforded different levels of protection by COVID vaccines?
- Vaccine effectiveness
- Direct protection vs transmission reduction
- National authorisations on vaccine use without SRA or WHO EUL/PQ
- COVID Vaccines and WHO/EUL
- Country and vaccine-specific information
- Russian vaccine (Gamaleya, Sputnik Vaccine)
- Chinese vaccines (Sinopharm (BBIBP and Wuhan Institute), Sinovac, Cansino, and West China Hospital+Sichuan University):
- Cuban Vaccine (Soberana 1 and Soberana 2):
- J&J
- SAGE Interim recommendations regarding Janssen and Janssen were developed on 15 March 2021 and will be available shortly afterwards.
- Vaccine uptake/hesitancy
- How might the WHO perceive vaccine hesitancy/resistance will be impacted by reported errors in the AstraZeneca vaccine’s clinical trials? Are there particular messages that will be more impactful as a result to help mitigate harm?
- Fighting misinformation
- Promoting public health messages to fill the vacuum
- Creating tools to amplify public health messages
- How might the WHO perceive vaccine hesitancy/resistance will be impacted by reported errors in the AstraZeneca vaccine’s clinical trials? Are there particular messages that will be more impactful as a result to help mitigate harm?
- Human vaccine and challenge trials
- Mandatory vaccinations and vaccination passports
- Questions regarding vaccine passports within countries
- Does the WHO support vaccine passports?
- How are WHO supporting the development of smart vaccine certificates?
- Vaccine pricing
- Are the prices COVAX have agreed with manufacturers been fixed for 2021 and beyond? Once COVAX’s goal of securing access to vaccines to cover 20% of a country’s population is achieved, will poorer countries be subject to higher prices?
- Reactive Holding statements / Questions
- What is the WHO’s advice regarding vaccinating athletes so that they can attend the Olympics Games which may take place in later in 2021?
- What are WHO thoughts on US joining COVAX?
- WHO statement on vaccine issues in occupied Palestinian Territories
- What is the WHO comment on the EU blocking vaccine exports?
- WHO’s work on vaccines
Covid-19 vaccine update from WHO: 10 March
We are sharing the new resources available to support COVID-19 vaccines introduction. For these resources and more, please visit the COVID-19 vaccines introduction toolbox, which provides guidance, tools, and training to equip all countries to prepare for and implement COVID-19 vaccination. For questions, comments or feedback, please e-mail: COVID19vaccineresources@who.int.
- The Monitoring COVID-19 Vaccination guidance provides considerations for: minimum and optional data to collect as vaccines are being rolled out and delivered; key performance indicators and the anticipated use of these—to measure the performance of key components of the immunization system and to take corrective action when needed; and the use of information systems to collect, store, analyze, and disseminate any relevant information. EN
- COVID-19 vaccination data are now available on the WHO Coronavirus (COVID-19) Dashboard: covid19.who.int. These data are viewed by selecting "Vaccination" from the dropdown panel on the left-hand side of the map. Currently, the dashboard incorporates information useful to track global vaccine roll-out, including total vaccination doses administered, persons vaccinated with at least one dose, and start date of vaccinations, by country, territory and area. More features (e.g., specifics on vaccine products authorized and administered and data downloads) will be added in the near future.
- The COVID-19 vaccine-specific resources course haslaunched on OpenWHO! Further videos and resources concerning othervaccines that receive emergency use listing (EUL) or prequalification will be added shortly. This mini-course includes short instructional videos and vaccine explainers on the handling, preparation, and administration of COVID-19 vaccines such as:
- AstraZeneca: The AstraZeneca ChAdOx1-S/nCoV-19 [recombinant] vaccine resource includes key information on the vaccine specific requirements. EN CH FR PT SP
- Moderna: The Moderna COVID-19 vaccine resource includes key information on the vaccine specific requirements. EN CH FR PT
- Pfizer/BioNTech: The Pfizer Comirnaty Tozinameran vaccine resource includes key information on the vaccine specific requirements. EN AR CH FR PT RU SP
- More information is now available about the COVAX No-Fault Compensation (NFC) Program for AMC Eligible Economies.The Program will be operational by 31 March 2021, with a web portal available at covaxclaims.com. Further information about the Program is available through this presentation which provides an overview of the Program. EN
- The COVID-19 vaccine checklist for frontline health workers job aid helps health workers to prepare and complete a COVID-19 vaccination session at a fixed post or outreach session. EN
- The COVID-19 Vaccination: Building Global Capacity webinars held by WHO and partners continueevery Tuesday from 12:00 to 13:00 CET (Interpretation into French and Spanish). You can watch the recordings of previous webinars and register for upcoming sessions here. Topics include:
Data Audience Topic 16 March Health workers Vaccine safety 23 March National/subnational Generating acceptance & demand for COVID-19 vaccines 30 March Health workers Reporting on COVID-19 vaccines (monitoring and AEFI) 6 April National/subnational Vaccination strategies for COVID-19 vaccination
WHO: February 2021
The WHO, UNICEF, Gavi and many other partners are working together to support countries in preparing for COVID-19 vaccination. Guidance, tools, and training are available to support Ministries of Health, health workers, partner organizations and others for COVID-19 vaccines rollout. These materials can be accessed on the COVID-19 vaccines country readiness and delivery section of the WHO website.
New WHO resources include:
- The COVID-19 vaccine demand package, which includes guidance, tools, and templates to generate acceptance and demand for COVID-19 vaccines.
- Acceptance and demand for COVID-19 vaccines: guidance for overall planning, 31 January 2021. Access link here
- Acceptance and demand for COVID-19 vaccines: planning template in Excel, 31 January 2021. Access link here
- Data for action: achieving high uptake of COVID-19 vaccines through measuring behavioral and social drivers, 3 February 2021. Access link here
- Conducting community engagement for COVID-19 vaccines, 31 January 2021. Access link here
- COVID-19 vaccines: misinformation management guide, December 2020. Access link here
- COVID-19 vaccine specific resources
WHO has developed vaccine-specific resources for COVID-19 vaccines that receive emergency use listing or prequalification. Additional resources and translations will be available shortly.
- Pfizer
- Moderna
- Supply and logistics guidance
- COVID-19 vaccination: Supply and logistics guidance helps national and subnational supply and logistics focal points to prepare and strengthen their supply chain strategies to receive, store, distribute and manage the COVID-19 vaccines and their ancillary products, in line with their national deployment and vaccination plan (NDVP). Access link here
- WHO Expanded Programme on Immunization Forecasting tool explains how to forecast the needs for vaccines, equipment for safe vaccination, as well as cold chain and ambient storage capacities for national immunization programmes. Access link here
- Training materials
- New job aides for vaccinators on how to prepare for COVID-19 vaccines have been added to the COVID-19 vaccination training for health workers and the Orientation to National Deployment and Vaccination Planning for COVID-19 Vaccines.
WHO - January 2021
Accelerator's Country Readiness and Delivery (CRD) workstream, focused on supporting readiness for the introduction of COVID-19 vaccines.
The CRD workstream is working on information materials, tools and training to support you, including a webpage with all the existing and upcoming country readiness and delivery resources (i.e. articles, briefs, and frequently asked questions), guidance documents such as the Guidance on developing a national deployment and vaccination plan for COVID-19 vaccines, and tools such as the COVID-19 Vaccine Introduction Readiness Assessment Tool – VIRAT/VRAF 2.0. Additionally, they are working on tools to support local strategies to generate acceptance and uptake of COVID-19 vaccines. These materials will be available via the CRD webpage shortly.
A range of COVID-19 vaccine introduction training packages are also available on OpenWHO and include e-learning modules, slides, and job aides. Two courses have recently been released:
- COVID-19 vaccination training for health workers provides information that health workers need to know to conduct COVID-19 vaccination.
- Orientation to national deployment and vaccination planning for COVID-19 vaccines provides orientation for national deployment and vaccination planning for COVID-19 vaccines.
APSR en bloc society news - December 2020 and January 2021
Respiratory Updates articles on the coronavirus:
20 December 2020
The Forum of International Respiratory Societies (FIRS), an organisation comprised of the world's leading international respiratory societies, calls for urgent access to affordable COVID-19 vaccines globally.
The COVID-19 pandemic has affected more than 72 million people worldwide and resulted in more than 1.6 million deaths to date. No country has been spared, and throughout the world this pandemic has placed a huge burden on health systems and on economies. Many countries are now experiencing a second wave of infections, which are more severe than the first initial wave. The elderly and those with underlying vulnerabilities including diabetes, chronic lung or heart disease, hypertension, obesity or immunosuppression are at higher risk for developing severe disease.
Incredibly, less than a year after the start of the pandemic, effective, safe vaccines are now being approved for emergency use and some countries have already started vaccinating their citizens. The rapid development and authorisation of these vaccines must be accompanied by close monitoring for further guidance and optimal use. However, roll out of vaccines is currently predominantly in high-income countries. There is an urgent need for affordable vaccines to be made available in low- and middle-income countries, especially as there may be limited access to health care and to life saving supportive therapy including oxygen in these settings.
"Now is a critical time in the fight against COVID-19. We need to ensure affordable, equitable access, transparency and fair distribution of approved vaccines to protect people in all countries." said Stephanie Levine, MD President of FIRS. "This pandemic has affected people around the world and we now need a global effort to ensure that all countries can access preventive, diagnostic and therapeutic measures to beat it."
17 April 2020
The Forum of International Respiratory Societies urges governments around the world to continue to support the WHO in the fight against COVID-19.
"More now than ever, the world's nations need to band together and pool resources in order to fight this global pandemic. Defunding WHO at such a critical time in our history is a dangerous step in the wrong direction.
FIRS urges the United States government and President Trump to immediately reconsider its decision,"
said Stephanie Levine, MD. President of FIRS.
firsnet.org/news-and-events/news-article/147-firs-statement-on-defunding-world-health-organization
14 April 2020
instagram.com/p/B-8pFHJl69f/?utm_source=ig_web_copy_link
(Click here if you cannot use Instagram)
February 2020
Inevitably, many planned conferences have been, and will be, rescheduled. Any such events we are made aware of are reflected in the calendar page. (Please inform the APSR Secretariat if you know of changes to any other event not shown on the Calendar.)
One of the most significant changes is to the APSR Congress in Kyoto originally scheduled for 15-18 October 2020, which will now take place a year later on 20-21 November 2021. The venue in Kyoto is unchanged.
The other significant change is for the APSR Congress in Seoul, which had been originally scheduled for 18-21 November 2021, and consequently will now take place on 17-20 November 2022.
By that time, we hope the coronavirus will be no longer a news item!
(No Covid-related Respirology articles published in the last few weeks)
to hide list)
Wang Chun Kwok, James Chung Man Ho, Terence Chi Chun Tam, Mary Sau Man Ip, David Chi Leung Lam; DOI: 10.1111/resp.14664
First published: 30 January 2024
Hayley Lewthwaite, Anthony Byrne, Bruce Brew, Peter G Gibson; DOI: 10.1111/resp.14596
First published: 16 September 2023
Tyler J Lane, Matthew Carroll, Brigitte M Borg, Tracy A McCaffrey, Catherine L Smith, Caroline X Gao, David Brown, David Poland, Shantelle Allgood, Jillian Ikin, Michael J Abramson; DOI: 10.1111/resp.14591
First published: 8 September 2023
Giacomo Sgalla, Paolo Maria Leone, Gina Gualano, Jacopo Simonetti, Alessia Comes, Diana Verdirosi, Francesco Di Gennaro, Anna Rita Larici, Stefania Ianniello, Giuseppe Cicchetti, Nicoletta Fusco, Marcello Pani, Fabrizio Palmieri, Luca Richeldi; DOI: 10.1111/resp.14575
First published: 21 August 2023
Camila Vitelli Molinari MSc, Vivian Bertoni Xavier PhD, Ronaldo Fernandes Rosa MSc, Maria Augusta Junqueira Alves MSc, Luiz Antônio Rivetti PhD, Vera Lúcia dos Santos Alves PhD; DOI: 10.1111/resp.14557
First published: 21 July 2023
Richard Beasley MBChB, DSc; DOI: 10.1111/resp.14519
First published: 18 May 2023
Chloe I Bloom; DOI: 10.1111/resp.14515
First published: 8 May 2023
Akihiro Ito, Tadashi Ishida, Yosuke Nakanishi, Hiroshi Kobe, Fumiaki Tokioka; DOI: 10.1111/resp.14509
First published: 27 April 2023
First published: 26 December 2022
Yoshitatsu Fukuta, Shinichi Arizono, Tomoya Yoshida, Yuji Mizuno, Masahiro Tawada, Junichi Magata, Takaki Uruno, Kazuki Watanabe, Akihiko Ozaki, Yoshinori Imaizumi; DOI: 10.1111/resp.14430
First published 4 December 2022
Debra Jean Phyland PhD, MAppSc, DipEd, BAppSc, FSPAA DOI: 10.1111/resp.14424
First published 30 November 2022
Grant Waterer MBBS, PhD DOI: 10.1111/resp.14423
First published 27 November 2022
Chi Chiu Leung MBBS, FCCP, FFPH; Andrew C K Lee MB ChB, MSc, MD, FRSPH, MFPH, MRCGP; DOI: 10.1111/resp.14403
First published 1 November 2022
Nobuyuki Horita MD, PhD; Takeshi Fukumoto MD, PhD; DOI: 10.1111/resp.14392
First published 17 October 2022
Adriano D S Targa, Iván D Benítez, Jessica González, Gerard Torres, Sally Santisteve, Rafaela Vaca, Olga Minguez, Maria Aguilà, Paola Carmona, Anna Moncusí-Moix, Clara Gort-Paniello, Gonzalo Labarca, Jesús Caballero, Carme Barberà, Antoni Torres, David de Gonzalo-Calvo, Ferran Barbé; DOI: 10.1111/resp.14390
First published 9 October 2022
Robert J Hancox MD; Catherina L Chang MD; DOI: 10.1111/resp.14376
First published 21 September 2022
Giusy Tiseo, Lorenzo Roberto Suardi, Lisa Giusti, Arianna Forniti, Claudio Caroselli, Valentina Galfo, Sara Occhineri, Alessandro Leonildi, Giovanna Moscato, Francesco Menichetti, Marco Falcone; DOI: 10.1111/resp.14372
First published: 16 September 2022
Daniel P Steinfort MBBS, PhD BMed Sci, Douglas F Johnson PhD; DOI: 10.1111/resp.14348
First published: 15 August 2022
Brigitte M Borg, Christian Osadnik, Keith Adam, David G Chapman, Catherine E Farrow, Vanda Glavas, Kerry Hancock, Celia J Lanteri, Ewan G Morris, Nicholas Romeo, Elena K Schneider-Futschik, Hiran Selvadurai; DOI: 10.1111/resp.14340
First published: 10 August 2022
Ludovico Messineo, Francesco Fanfulla, Leonardo Pedroni, Floriana Pini, Andrea Borghesi, Salvatore Golemi, Guido Vailati, Kayla Kerlin, Atul Malhotra, Luciano Corda, Scott Sands; DOI: 10.1111/resp.14336
First published: 07 August 2022
Elizabeth G Ryan, Dominique-Laurent Couturier, Stephane Heritier; DOI: 10.1111/resp.14337
First published: 02 August 2022
Grant Waterer MD, PhD; DOI: 10.1111/resp.14331
First published: 18 July 2022
Alireza Mirahmadizadeh, Ali Semati, Alireza Heiran, Mostafa Ebrahimi, Abdolrasool Hemmati, Mohammadreza Karimi, Souzan Basir, Marjan Zare, Antonio Charlys da Costa, Mohammad Zeinali, Maryam Sargolzaee, Owrang Eilami; DOI: 10.1111/resp.14318
First published: 23 June 2022
Atsuyuki Watanabe, Matsuo So, Masao Iwagami, Koichi Fukunaga, Hisato Takagi, Hiroki Kabata, Toshiki Kuno; DOI: 10.1111/resp.14311
First published 12 June 2022
A collection of rigorous research studies, insightful expert reviews and informative opinion pieces by authorities in the field, has been expertly selected and reviewed by the Deputy Editor and WHO advisor Professor David S C Hui, and Dr Ken K P Chan from the Chinese University of Hong Kong. Their review is the first paper in the collection. DOI: toc/10.1111/(ISSN)1440-1843.2021-Respirology-publications-on-COVID19
First published 9 June 2022
Ken K P Chan, David S C Hui; DOI: 10.1111/resp.14305
First published 7 June 2022
Fabian Theurl MD, Nikolay Sappler MD, Konstantinos D. Rizas MD, Steffen Massberg MD, Axel Bauer MD, Michael Schreinlechner MD; DOI: 10.1111/resp.14306
First published 7 June 2022
Joo Koh MBBS; Malcolm Baxter FRACS; Debra Phyland PhD; Laurence Ruane MSc; Adriana Avram RN; Elizabeth Leahy RN; Kenneth Lau FRANZCR; Martin MacDonald FRACP, PhD; Paul Leong FRACP, PhD; Philip Bardin FRACP, PhD; DOI: 10.1111/resp.14276
First published 4 May 2022
Natasha Smallwood BMedSci, MBBS, MSc, AFRACMA, FRCP, FRACP, PhD; Jaimie-Lee Maple BPsychSc (Hons), PhD; Karen Willis BA, MA, GradDipHealthProm, PhD; DOI: 10.1111/resp.14266
First published: 26 April 2022
- in reply to:
Impact of the COVID-19 crisis on healthcare workers: The need to address quality of working life issuesFabienne Marcellin PhD; Lorraine Cousin PhD; Vincent Di Beo MSc; Véronique Mahé MD; Olivia Rousset-Torrente MSc; Patrizia Carrieri PhD; Olivier Chassany MD, PhD; Martin Duracinsky MD, PhD; DOI: 10.1111/resp.14265
First published: 26 April 2022
Gizal Nakshbandi, Catharina C Moor, Esther J Nossent, J J Miranda Geelhoed, Sara J Baart, Bart G Boerrigter, Joachim G J V Aerts, Suzan F M Nijman, Helger Y Santema, Merel E Hellemons, Marlies S Wijsenbeek; DOI: 10.1111/resp.14262
First published 19 April 2022
Sarah M Fairweather BSc, Catherina L Chang MD, Robert J Hancox MD. DOI: 10.1111/resp.14260
First published 12 April 2022
Yoichi Nakanishi MD, PhD. DOI: 10.1111/resp.14251
First published 24 March 2022
Benjamin M Kagina PhD, Carine Dochez PhD; DOI: 10.1111/resp.14236
First published 28 February 2022
Shane A Landry, Dinesh Subedi, Martin I MacDonald, Samantha Dix, Donna M Kutey, Jeremy J Barr, Darren Mansfield, Garun S Hamilton, Bradley A Edwards, Simon A Joosten; DOI: 10.1111/resp.14227
First published 13 February 2022
Natasha Smallwood, Warren Harrex, Megan Rees, Karen Willis, Catherine M Bennett; DOI: 10.1111/resp.14208
First published 19 January 2022
Man Man Niu MD, Guo Zhen Fan MD, Rui Xue Li MD, Qi Jiang MD, Peng Hu MD PhD; DOI: 10.1111/resp.14207
First published 17 January 2022
Mark Lavercombe MBBS, SpecCertClinLead, GDipClinEd, FRACP, FCCP, FAPSR DOI: 10.1111/resp.14201
First published 4 January 2022
Bruce W S Robinson AM, MBBS, MD, FRACP, FRCP, DTM&H, FCCP, CitWA, FAAHMS, University of Western Australia; Anna Tai MBChB, FRACP, PhD; Kyle Springer BSc, MA DOI: 10.1111/resp.14199
First published 30 December 2021
Chris Ka Pun Mok, Carolyn A Cohen, Samuel M S Cheng, Chunke Chen, Kin-On Kwok, Karen Yiu, Tat-On Chan, Maireid Bull, Kwun Cheung Ling, Zixi Dai, Susanna S Ng, Grace Chung-Yan Lui, Chao Wu, Gaya K Amarasinghe, Daisy W Leung, Samuel Yeung Shan Wong, Sophie A Valkenburg, Malik Peiris, David S Hui DOI: 10.1111/resp.14191
First published 24 November 2021
Nobuyuki Horita MD, PhD; Hideaki Kato MD, PhD; Keisuke Watanabe MD, PhD; Yu Hara MD, PhD; Nobuaki Kobayashi MD, PhD; Takeshi Kaneko MD, PhD DOI: 10.1111/resp.14186
First published 21 November 2021
Jennifer Perret MBBS, FRACP, PhD,Shyamali Dharmage MBBS, MD, PhD; DOI: 10.1111/resp.14179
First published 3 November 2021
Christos Kyriakopoulos, Georgios Ntritsos, Athena Gogali, Haralampos Milionis, Evangelos Evangelou, Konstantinos Kostikas; DOI: 10.1111/resp.14152
First published 3 October 2021
Angelico Mendy, Xiao Wu, Jason L Keller, Cecily S Fassler, Senu Apewokin, Tesfaye B Mersha, Changchun Xie, Susan M Pinney; DOI: 10.1111/resp.14140
First published 30 August 2021
Biplab K Saha MD, Praveen Chenna MD; DOI: 10.1111/resp.14131
First published 13 August 2021
Sarah M Fairweather, Catherina L Chang, Christopher J Mansell, Eskandarain Shafuddin, Robert J Hancox; DOI: 10.1111/resp.14119
First published 8 August 2021
Lianhan Shang, David Chien Lye, Bin Cao; DOI: 10.1111/resp.14106
First published 8 July 2021
Tai Joon An, Youlim Kim, Yong Bum Park, Kyungjoo Kim, Do Yeon Cho, Kwang-Ha Yoo, Chin Kook Rhee; DOI: 10.1111/resp.14108
First published 26 June 2021
Azar Kianzad, Lilian J Meijboom, Esther J Nossent, Eva Roos, Bernadette Schurink, Peter I Bonta, Inge A H van den Berk, Rieneke Britstra, Jaap Stoker, Anton Vonk Noordegraaf, Paul van der Valk, Erik Thunnissen, Marianna Bugiani, Harm Jan Bogaard, Teodora RadonicTai Joon An, Youlim Kim, Yong Bum Park, Kyungjoo Kim, Do Yeon Cho, Kwang-Ha Yoo, Chin Kook Rhee; DOI: 10.1111/resp.14101
First published 22 June 2021
Mark É Czeisler, Jessica L Kennedy, Joshua F Wiley, Elise R Facer-Childs, Rebecca Robbins, Laura K Barger, Charles A Czeisler, Shantha M W Rajaratnam, Mark E Howard; DOI: 10.1111/resp.14094
First published 3 June 2021
Ashwin Balu MB ChB, Alastair Watson PhD, Lucie Linhartova FRCA, FFICM, Paul Ellis MRCP, Rahul Mukherjee FRCP (London), FRCP (Edin.), FCCP; DOI: 10.1111/resp.14090
First published: 28 May 2021
Siddharth Sridhar, John Nicholls; DOI: 10.1111/resp.14091
First published: 26 May 2021
Askin Gülsen; Inke R. König; Uta Jappe; Daniel Drömann; DOI: 10.1111/resp.14049
First published 6 May 2021
Michael J. Maze MB ChB, DCH, DTM&H, PhD, FRACP; DOI: 10.1111/resp.14067
First published 5 May 2021
Ricardo Wesley Alberca PhD; DOI: 10.1111/resp.14043
First published 13 April 2021
Hugo Farne PhD, Aran Singanayagam PhD; DOI: 10.1111/resp.14039
First published 16 March 2021
Kin On Kwok, Ying Huang, Margaret Ting Fong Tsoi, Arthur Tang, Samuel Yeung Shan Wong, Wan In Wei, David Shu Cheong Hui; DOI: 10.1111/resp.14026
First published 9 March 2021
Avinash Aujayeb MBBS, MRCP (Edin 2008), PGCertClinEd, FHEA; DOI: 10.1111/resp.14035
First published 8 March 2021
Waheed Shah MB, Orla O'Carroll MD, Michael P Keane MD, Cormac McCarthy MB, PhD; DOI: 10.1111/resp.14034
First published 7 March 2021
Garun S Hamilton MBBS, FRACP, PhD; DOI: 10.1111/resp.14031
First published 3 March 2021
Jennifer R A Jones DPT BSc; Zachary Attard DPT BBiomedSc; Rinaldo Bellomo MBBS MD FRACP FCICM PGDipEcho; Nicola Burgess DPT BBiotechMedRes; Ashleigh Donovan DPT BHSc (Hons); Marnie Graco PhD MPH BPhysio; Thomas Rollinson BPhysio; David J Berlowitz PhD PGradDipPhty BAppSciPhty; DOI: 10.1111/resp.14008
First published 27 January 2021
Peter A B Wark, Prabuddha S Pathinayake, Gerard Kaiko, Kristy Nichol, Ayesha Ali, Ling Chen, Erika N Sutanto, Luke W Garratt, Sukhwinder S Sohal, Wenying Lu, Mathew S Eapen, Christopher Oldmeadow, Nathan Bartlett, Andrew Reid, Punnam Veerati, Alan C-Y Hsu, Kevin Looi, Thomas Iosifidis, Stephen M Stick, Philip M Hansbro, Anthony Kicic; DOI: 10.1111/resp.14003
First published 17 January 2021
Michael P Gantier PhD; DOI: 10.1111/resp.13997
First published 21 December 2020
Song-I Lee MD; Jeong Suk Koh MD; Yoon Joo Kim MD; Da Hyun Kang MD, PhD; Dongil Park MD, PhD; Hee Sun Park MD, PhD; Sung Soo Jung MD, PhD; Ju-Ock Kim MD, PhD; Jeong Eun Lee MD, PhD; DOI: 10.1111/resp.13992
First published 21 December 2020
Tracy L Leong MBBS (Hons), FRACP, MPH, PhD; DOI: 10.1111/resp.13996
First published 15 December 2020
Christine Jenkins AM, MD, FRACP; Anthony Sunjaya MD, SM; DOI: 10.1111/resp.13990
First published 15 December 2020
Sarah Williams; Natasha Sheard; Beth Stuart; Hang T T Phan; Florina Borca; Tom M A Wilkinson; Hannah Burke; Anna Freeman on behalf of the REACT COVID Investigators; DOI: 10.1111/resp.13985
First published 6 December 2020
Yasser Noeman-Ahmed, Sriya Gokaraju, Duncan J Powrie, Dora A Amran, Iman El Sayed, Ashraf Roshdy; DOI: 10.1111/resp.13964
First published 2 November 2020
Alistair Miller MBBS, FRACP, PhD, Emily Stone MBBS, MMed, FRACP; DOI: 10.1111/resp.13968
First published 28 October 2020
Xuandong Jiang MM, Kailei Du MM, Ya Zhang MM; DOI: 10.1111/resp.13962
First published 13 October 2020
Philip G Bardin FRACP, PhD Sebastian L Johnston FRCP, PhD; DOI: 10.1111/resp.13961
First published 13 October 2020
Ajay Prashad Gautam PhD Ross Arena PhD, PT2 Snehil Dixit MPT, PhD Audrey Borghi-Silva PhD, PT; DOI: 10.1111/resp.13946
First published 21 September 2020
Karolina Akinosoglou MD, PhD Charalambos Gogos MD, PhD; DOI: 10.1111/resp.13939
First published 20 September 2020
Priyanka Makkar MD Stephen M Pastores MD, MACP, FCCP, FCCM; DOI: 10.1111/resp.13941
First published 14 September 2020
Paul A Komesaroff MB, BS, BSc(Hons), PhD, FRACP; DOI: 10.1111/resp.13930
First published 29 August 2020
Marie Bruyneel, Maria Gabrovska, Peter Rummens, Alain Roman, Marc Claus, Etienne Stevens, Philippe Dechamps, Lucas Demey, Laurent Truffaut, Vincent Ninane
DOI: 10.1111/resp.13932
First published 25 August 2020
Christopher Chew MBBS (Hons), BMedSc (Hons), MBioethics; Danielle Ko LLB (Hons), BA, MBBS (Hons), FRACGP, FAChPM; DOI: 10.1111/resp.13927
First published 5 August 2020
Shane A Landry, Dwayne L Mann, Lee Djumas, Ludovico Messineo, Philip I Terrill, Luke D J Thomson, Caroline J Beatty, Garun S Hamilton, Darren Mansfield, Bradley A Edwards, Simon A Joosten; DOI: 10.1111/resp.13922
First published 3 August 2020
Cormac McCarthy, Stefano Savinelli, Eoin R Feeney, Marcus W Butler, Cathal O'Broin, Silke Ryan, Lorraine O'Neill, David J Murphy, Charles G Gallagher, Edward F McKone, Sarmad Waqas, Aoife Cotter, Peter Doran, Michael P Keane, Patrick W Mallon; DOI: 10.1111/resp.13912
First published 21 July 2020
Christopher Liu OBE, FRCOphth, FRCSEd, FRCP, CertLRS; Rawya Diab MBBS, MD, MRCSEd, FICO; Hasan Naveed MBBS, BSc (Hons); Victor Leung MSc, CIH, ROH, CRSP; DOI: 10.1111/resp.13892
First published 6 July 2020
Venktesh R Ramnath MD; Kristina Kairaitis MD PhD; Atul Malhotra MD; DOI: 10.1111/resp.13894
First published 1 July 2020
Risa Ebina-Shibuya MD, PhD; Nobuyuki Horita MD, PhD; Ho Namkoong MD, PhD; Takeshi Kaneko MD, PhD; DOI: 10.1111/resp.13885
First published 18 June 2020
Tomas Raul Wiche Salinas MD, PhD(c); Boyang Zheng MD; Jean-Pierre Routy MD; Petronela Ancuta PhD; DOI: 10.1111/resp.13875
First published 17 June 2020
Martyn A French MBChB, MD, FRCPath, FRCP, FRACP; Yuben Moodley MBChB, FCP, FRACP, MD, PhD
DOI: 10.1111/resp.13852
First published 20 May 2020
Xiao-Neng Mo, Zhu-Quan Su, Chun-Liang Lei, Di-Fei Chen, Hui Peng, Ru-Chong Chen, Ling Sang, Hong-Kai Wu, Shi-Yue Li
DOI: 10.1111/resp.13840
First published 14 May 2020
Daniel P Steinfort, Felix J F Herth, Louis B Irving, Phan T Nguyen
DOI: 10.1111/resp.13843
First published 13 May 2020
Srinadh Annangi
DOI: 10.1111/resp.13845
First published 11 May 2020
Anthony Paulo Sunjaya MD, SM; Christine Jenkins MD, AM, FRACP
DOI: 10.1111/resp.13834
First published 30 April 2020
Siobhain Mulrennan MB ChB, MRCP, MD, FRACP; Henri Colt MD, FCCP, FAWM
DOI: 10.1111/resp.13832
First published 28 April 2020
Robert J Lentz MD and Henri Colt MD, FCCP, FAWM
DOI: 10.1111/resp.13824
First published 11 April 2020
to hide list)
Stephen T Holgate KBE, FMedSci; DOI: 10.1111/resp.14661
First published 23 January 2024
Christine F McDonald MBBS(Hons), PhD, FRACP, F Thor Soc, FAHMS; DOI: 10.1111/resp.14655
First published 4 January 2024
Roberto A Accinelli MD, MPH; DOI: 10.1111/resp.14599
First published 12 September 2023
Rogelio Pérez-Padilla MD; DOI: 10.1111/resp.14573
First published 18 August 2023
CEdward J Schenck MD, Meredith L Turetz MD, Michael S Niederman MD; DOI: 10.1111/resp.14561
First published 26 July 2023
Cynthia Farrugia Jones MD, FRCP(Lon), FRCP(Edin), PG Dip Med Ed (Dundee); Brendan Caruana Montalto MD, FACP; DOI: 10.1111/resp.14483
First published 8 March 2023
Eva Tedlova MD, PhD; Magda Suchankova MD, PhD; DOI: 10.1111/resp.14396
First published 20 October 2022
Saroj Jayasinghe MBBS, MD, MRCP, MD, PhD, FRCP, FCCP, FNASSL; DOI: 10.1111/resp.14393
First published 17 October 2022
Tom Hills MBChB, MSc, DPhil; Richard Beasley MBChB, DM, DSc; DOI: 10.1111/resp.14375
First published 18 September 2022
Michael Schreinlechner MD, Fabian Theurl MD, DOI: 10.1111/resp.14330
First published 14 July 2022
Mohammed S Al Harrasi MD, Nabil M Al Lawati MD; DOI: 10.1111/resp.14255
First published 30 March 2022
Ohoud Aljuhani PharmD, BCCCP; Khalid Al Sulaiman BCCCP, BCNSP, MBA; DOI: 10.1111/resp.14239
First published 11 March 2022
Ramy Mohamed Ghazy DrPH, Sarah Hamed N. Taha PhD, Yasir Ahmed Mohammed Elhadi BPharm; DOI: 10.1111/resp.14205
First published 9 January 2022
Achyut Bhakta Acharya MBBS, MD, DM, Narendra Bhatta MBBS, MD, MSc, FNCCP, FAPSR, FCCP (USA), Deebya Raj Mishra MBBS, MD, DM, European Diploma in Respiratory Medicine, Prahlad Karki MBBS, MD, FICC, FACC, FESC, Mukesh Kumar Gupta MBBS, MD, Madhab Lamsal MSc, PhD, Basuda Khanal MBBS, MD; DOI: 10.1111/resp.14198
First published 30 December 2021
María Fernanda del Valle; Jorge Valenzuela; Loretto Godoy; Mariano del Sol; Pablo A Lizana; Máximo Escobar-Cabello; Rodrigo Muñoz-Cofre DOI: 10.1111/resp.14196
First published 15 December 2021
Semra Bilaçeroğlu MD; DOI: 10.1111/resp.14124
First published 1 August 2021
Diane M. Gray MBChB, PhD; DOI: 10.1111/resp.14104
First published 30 June 2021
Muhammad Imran MBBS, FCPS; Sajjad Khan MBBS, MPH; Shahid Khan MBBS, MPH; Azhar Uddin MBBS, FCPS; Muhammad Salman Khan MBBS; Preshit Ambade BAMS, MHA, DrPH; DOI: 10.1111/resp.14093
First published 31 May 2021
Bo Lundbäck MD, PhD, FERS; Lowie E G W Vanfleteren MD, PhD; DOI: 10.1111/resp.14065
First published 5 May 2021
Konstantinos Kostikas MD, PhD, FCCP, FERS; DOI: 10.1111/resp.14060
First published 16 April 2021
Syazatul Syakirin Sirol Aflah MD; Alif Adlan Mohd Thabit MB BCH BAO; Suresh Kumar Chidambaram MBBS; DOI: 10.1111/resp.14057
First published 11 April 2021
Jennifer Ann Wi MD, FPCP, FPCCP, FCCP, FAPSR; DOI: 10.1111/resp.14051
First published 8 April 2021
Stephan F van Eeden MD, PhD; DOI: 10.1111/resp.14027
First published 1 March 2021
Jiuyang Xu MDc Bin Cao MD; DOI: 10.1111/resp.14002
First published 5 January 2021
Zhaowei Yang PhD Jing Li MD; DOI: 10.1111/resp.13998
First published 2 January 2021
Shu Hashimoto MD, PhD; Mari Hikichi MD, PhD; Shuichiro Maruoka MD, PhD; Yasuhiro Gon MD, PhD; DOI: 10.1111/resp.13989
First published 8 December 2020
Keiko Kan-o MD, PhD; DOI: 10.1111/resp.13986
First published 2 December 2020
Sheiphali A Gandhi MD, MPH; DOI: 10.1111/resp.13980
First published 18 November 2020
Sarah Diver MBChB; Chris Brightling PhD; Chandra Ohri MD; DOI: 10.1111/resp.13957
First published 19 October 2020
Anne-Marie Russell PhD, RN, RHV, LPE, ATSF; DOI: 10.1111/resp.13954
First published 12 October 2020
Faisal Yunus MD, PhD, FCCP, FISR Sita Andarini MD, PhD, FISR; DOI: 10.1111/resp.13953
First published 7 October 2020
Ebrahim Abbasi-Oshaghi PhD Fatemeh Mirzaei PhD Iraj Khodadadi PhD; DOI: 10.1111/resp.13948
First published 15 September 2020
Sanjay H Chotirmall MD, PhD; Lin-Fa Wang PhD; John A Abisheganaden MD; DOI: 10.1111/resp.13929
First published 17 August 2020
Jérémy Charriot MD; Laurie Pahus PharmD, PhD; Pascal Chanez MD, PhD; Nicolas Nagot MD, PhD; Arnaud Bourdin MD, PhD DOI: 10.1111/resp.13874
First published 8 June 2020
Wei-jie Guan MD and Nan-shan Zhong MD
DOI: 10.1111/resp.13817
First published 8 April 2020
In addition to COVID-19 articles, a special Respirology collection includes information and lessons learnt from previous pandemics.
A collection of articles on COVID-19 and earlier coronaviruses can be read here.
(No Covid-related Respirology Case Reports articles published in the last few weeks)
to hide list)
Makiko Yomota, Masaru Tanaka, Takayuki Kobayashi, Masatake Kitano, Saori Ikeda, Yusuke Kanemasa, Noriyo Yanagawa, Yukio Hosomi; DOI: 10.1002/rcr2.1298
First published: 20 February 2024
Hwan Jin Lee, So Ri Kim; DOI: 10.1002/rcr2.1300
First published: 14 February 2024
Takuma Katano, Tomoyuki Ogisu, Akira Satou, Toshiyuki Yonezawa, Hiroyuki Tanaka, Satoru Ito; DOI: 10.1002/rcr2.1294
First published: 07 February 2024
David J F Smith, Jamilah Meghji, Mufaddal Moonim, Clare Ross, Patrizia Viola, Melissa Wickremasinghe, Laura E Gleeson; DOI: 10.1002/rcr2.1231
First published 13 October 2023
Cheuk Cheung Derek Leung, Yiu Cheong Yeung; DOI: 10.1002/rcr2.1229
First published 26 September 2023
Kei Yamasaki, Taiki Manabe, Yuto Iwanaga, Ryota Akaike, Toshinori Kawanami, Kazuhiro Yatera; DOI: 10.1002/rcr2.1198
First published 5 July 2023
Nikko John Dalisay, Bernice Ong-dela Cruz, Percival Punzal, Ma. Encarnita Limpin; DOI: 10.1002/rcr2.1187
First published 5 July 2023
Andrew Macdonald, Cameron Butcher, Thuy Nhu Nguyen; DOI: 10.1002/rcr2.1145
First published 20 April 2023
Sato Nakamura, Yukio Kawagishi, Akihiro Kikushima, Atsushi Muto, Yoshifumi Suda, Kazuki Gohara, Shinichi Takeda; DOI: 10.1002/rcr2.1151
First published 20 April 2023
Nghia Thinh Bui, Minh Nhat Huynh, Hung Tran, Dinh Kha Le, Tan Thanh Pham, Thanh Tung Pham, Tien Nhan Nguyen, Nguyen-Huy Do-Tran, Hoang-Anh Ngo, Thuy-Anh Do; DOI: 10.1002/rcr2.1139
First published 5 April 2023
Mohamed Tayeb Salaouatchi, Linda Spinato, Said Sanoussi, Maria do Carmo Filomena Mesquita; DOI: 10.1002/rcr2.1127
First published 26 March 2023
Nahid Borna, Maryam Niksolat, Behnam Shariati, Vahid Saeedi, Leila Kamalzadeh; DOI: 10.1002/rcr2.1121
First published 16 March 2023
Mohamed Tayeb Salaouatchi, Linda Spinato, Said Sanoussi, Maria do Carmo Filomena Mesquita; DOI: 10.1002/rcr2.1127
First published 26 March 2023
Nahid Borna, Maryam Niksolat, Behnam Shariati, Vahid Saeedi, Leila Kamalzadeh; DOI: 10.1002/rcr2.1121
First published 16 March 2023
Wei-Chiang Lin, Shang-Yi Lin, Meng-Che Tsai, Fu-Tsai Chung, Hsiu-Mei Chang; DOI: 10.1002/rcr2.1107
First published 14 February 2023
Takahiro Shimizu, Hiroki Shirasaki, Kazuhiro Okafuji, Aiko Sawazaki, Tasuku Iwabuchi, Ryo Matubayashi; DOI: 10.1002/rcr2.1099
First published 9 February 2023
Salim Ramadan, The Thanh Diem Nguyen, Sophie Laberge, Jacques-Edouard Marcotte, Zofia Zisman-Colman, Sze Man Tse; DOI: 10.1002/rcr2.1077
First published 22 December 2022
Yu Suzuki, Takaaki Ogoshi, Yusuke Taura, Shiori Oda, Daiji Uchiyama, Hiroyuki Ueda, Kazuhiro Yatera; DOI: 10.1002/rcr2.1071
First published 8 December 2022
Hiroaki Nagano, Sara Takaesu; DOI: 10.1002/rcr2.1070
First published 8 December 2022
Saeko Takahashi, Ai Kato, Kanako Hashimoto, Tomohiro Takehara, Kota Ishioka, Satoshi Takanashi; DOI: 10.1004/rcr2.1062
First published: 2 November 2022
Satoshi Ikeo, Toshiyuki Iwata, Naoaki Yasuda, Yasuyuki Hayashi, Akihiko Sokai, Takashi Nishimura; DOI: 10.1002/rcr2.1062
First published: 28 October 2022
Keishi Sugino, Hirotaka Ono, Mikako Saito, Masahiro Ando, Eiyasu Tsuboi; DOI: 10.1002/rcr2.1051
First published: 12 October 2022
Hui Xin Tan, Chee Kin Wong, Weng Fai Yik, Yoke Fong Lam, Kumaresh Raj Lachmanan; DOI: 10.1002/rcr2.1042
First published: 29 September 2022
Saria Tasnim, Ola Al-Jobory, Ahmad Hallak, Taru Bharadwaj, Manish Patel; DOI: 10.1002/rcr2.1026
First published: 18 September 2022
Dujrath Somboonviboon, Anan Wattanathum, Narumon Keorochana, Kittisak Wongchansom; DOI: 10.1002/rcr2.1016
First published: 11 August 2022
Hafizah Abdullah, Yen Shen Wong, Muhammad Amin Ibrahim, Aisya Natasya Musa, Thevaraajan Jayaraman, Mohd Arif Mohd Zim; DOI: 10.1002/rcr2.1013
First published: 2 August 2022
Aida Borgi, Assaad Louati, Amal Miraoui, Lilia Lahmar, Khaoula Mefteh, Ahmed Hajji, Ahmed Ayari, Asma Bouziri, Khaled Menif, Hanen Smaoui, Nejla Benjaballah; DOI: 10.1002/rcr2.1012
First published: 30 July 2022
Maki Asami-Noyama, Misa Harada, Yukari Hisamoto, Taiga Kobayashi, Keiji Oishi, Nobutaka Edakuni, Tsunahiko Hirano, Tomoyuki Kakugawa, Kazuto Matsunaga; DOI: 10.1002/rcr2.1009
First published 19 July 2022
Tomohiro Bando, Reoto Takei, Yoshikazu Mutoh, Hajime Sasano, Yasuhiko Yamano, Toshiki Yokoyama, Toshiaki Matsuda, Kensuke Kataoka, Tomoki Kimura, Yasuhiro Kondoh DOI: 10.1002/rcr2.995
First published 4 July 2022
Hisashi Sasaki, Jun Miyata, Ai Kobayashi, Shuichi Kawano, Akihiko Kawana DOI: 10.1002/rcr2.979
First published 7 June 2022
Amirmasoud Taheri, Lotfollah Davoodi, Eissa Soleymani, Noushin Ahmadi. DOI: 10.1002/rcr2.978
First published 22 May 2022
Dujrath Somboonviboon, Anan Wattanathum. DOI: 10.1002/rcr2.963
First published 11 May 2022
Esther Palones, Virginia Pajares, Laura López, Diego Castillo, Alfons Torrego. DOI: 10.1002/rcr2.955
First published 27 April 2022
Tomohiro Yoshikawa, Katsuyoshi Tomomatsu, Eriko Okazaki, Tomoe Takeuchi, Yukihiro Horio, Yusuke Kondo, Tsuyoshi Oguma, Koichiro Asano. DOI: 10.1002/rcr2.944
First published 29 March 2022
Jin Lee Lim, Inn Shih Khor, Cheng Keat Moh, Yi Min Chan, Yoke Fong Lam, Kumaresh Raj Lachmanan. DOI: 10.1002/rcr2.940
First published 27 March 2022
Clara So, Shinyu Izumi, Akane Ishida, Ryo Hirakawa, Yusaku Kusaba, Masao Hashimoto, Satoru Ishii, Hideki Miyazaki, Motoyasu Iikura, Masayuki Hojo; DOI: 10.1002/rcr2.938
First published 23 March 2022
Esperanza Figueroa-Hurtado, Diana Lizbeth Ortíz-Farias, Isabel Sada-Ovalle, Sandra Yareth Maldonado-Ortíz, Jorge Arturo Valdivieso-Jiménez, Arturo Cortes-Telles; DOI: 10.1002/rcr2.920
First published 22 March 2022
Kohei Hashimoto, Takako Kawaguchi, Kei Yamasaki, Hiroaki Ikegami, Toshinori Kawanami, Kazuhiro Yatera; DOI: 10.1002/rcr2.933
First published 16 March 2022
Akiko Tamura, Ryosuke Imai, Yutaka Tomishima, Naoki Nishimura; DOI: 10.1002/rcr2.934
First published 16 March 2022
Chie Morita, Atsushi Kitamura, Kohei Okafuji, Shosei Ro, Ryosuke Imai, Kasumi Shirasaki, Yu Watanabe,Naoki Nishimura; DOI: 10.1002/rcr2.923
First published 13 March 2022
Tomoya Horiguchi, Tetsuya Tsukamoto, Yoko Toyama, Toshiharu Sasaki, Tomoyuki Nakamura, Aki Sakurai, Naohide Kuriyama, Satoshi Komatsu, Yoshiko Shigeyasu, Takuma Ina, Eiko Sakurai, Noriko Nakajima, Arisa Tsuchimori, Seiji Yamada, Tadaki Suzuki, Kazuyoshi Imaizumi; DOI: 10.1002/rcr2.912
First published 13 February 2022
Francesco Satriano, Giulia Scioscia, Maria Grazia Cagnazzo, Federica Maci, Leonida Refolo, Paolo Fuso, Emanuele Gerardi, Diego Grasso, Piera Soccio, Donato Lacedonia; DOI: 10.1002/rcr2.836
First published 22 January 2022
Phool Iqbal, Sinda Dakhlia, Sara Seife Hassen, Salah Mahdi; DOI: 10.1002/rcr2.905
First published 19 January 2022
Jamie R Felzer, Delvise T Fogwe, Shaher Samrah, Clement J Michet Jr, Ulrich Specks, Misbah Baqir, Aahd F Kubbara; DOI: 10.1002/rcr2.894
First published 27 December 2021
Sokichi Kamata, Souhei Hamanaka, Jin Tsukamoto, Teppei Tsuchimoto, Kiyohiro Fujiwara, Mikio Okamura; DOI: 10.1002/rcr2.889
First published 17 December 2021
Jefferson Daniel, Balamugesh Thangakunam, Barney Thomas Jesudason Isaac, Mahesh Moorthy, Devasahayam Jesudas Christopher; DOI: 10.1002/rcr2.891
First published 7 December 2021
Hiroshi Kobe, Akihiro Ito, Tadashi Ishida; DOI: 10.1002/rcr2.886
First published 1 December 2021
Frini Karaolidou, Natasa-Eleni Loutsidi, Zois Mellios, Edison Jahaj, Konstantinos Eleftheriou, Maria Pagoni, Ioannis Mpaltadakis, Athanasios-Meletios Dimopoulos, Ioannis Kalomenidis, Apostolos G Pappas; DOI: 10.1002/rcr2.858
First published 9 November 2021
Po-Hao Chen, Chun-Yuan Cheng, Li-Fu Li, Chung-Chieh Yu; DOI: 10.1002/rcr2.869
First published 24 October 2021
Pratibha Gogia, Sandeep Attawar, Vivek Singh, Tarun Bhatnagar, Sanjay Sharma, Khushboo Batra, Swapnil Khare; DOI: 10.1002/rcr2.862
First published 19 October 2021
Pei-Yee Onn, Catherina L Chang; DOI: 10.1002/rcr2.860
First published 4 October 2021
Keima Ito, Takako Yokoyama, Minoru Horiuchi, Munehiro Kato, Ikuji Usami; DOI: 10.1002/rcr2.821
First published 3 August 2021
Saori Amiya, Haruhiko Hirata, Takayuki Shiroyama, Yuichi Adachi, Takayuki Niitsu, Yoshimi Noda, Takatoshi Enomoto, Reina Hara, Kiyoharu Fukushima, Yasuhiko Suga, Kotaro Miyake, Moe Koide, Akinori Uchiyama, Yoshito Takeda, Atsushi Kumanogoh; DOI: 10.1002/rcr2.801
First published 8 June 2021
Desdiani Desdiani, Nita Yulianti, Anindita Basuki; DOI: 10.1002/rcr2.793
First published 8 June 2021
Takahito Nakano, Masahiro Kawada, Kensuke Minami, Hiroyuki Kaneda; DOI: 10.1002/rcr2.785
First published 26 May 2021
Haruko Matsumoto, Shigeo Hanada, Kazumasa Yamamoto, Hisashi Takaya; DOI: 10.1002/rcr2.787
First published 26 May 2021
Bushra Johari; Roqiah Fatmawati Abdul Kadir; Farihah Abd Ghani; Alan Basil Peter; DOI: 10.1002/rcr2.764
First published 4 May 2021
Shosei Ro; Ryosuke Imai; Atsushi Kitamura; Torahiko Jinta; Naoki Nishimura; DOI: 10.1002/rcr2.761
First published 4 May 2021
Sumitaka Yamanaka, Shinichiro Ota, Yukihiro Yoshida, Masaharu Shinkai; DOI: 10.1002/rcr2.751
First published 8 April 2021
Hiroaki Ogata, Taisuke Nakagawa, Soichiro Sakoda, Akiko Ishimatsu, Kazuhito Taguchi, Masako Kadowaki, Atsushi Moriwaki, Makoto Yoshida; DOI: 10.1002/rcr2.744
First published 30 March 2021
Nophol Leelayuwatanakul, Napplika Kongpolprom, Thitiwat Sriprasart, Vorakamol Phoophiboon, Vorawut Thanthitaweewat, Sarita Thawanaphong, Worawan Sirichana, Naricha Chirakalwasan, Kamon Kawkitinarong, Chanchai Sittipunt, Opass Putcharoen, Leilani Paitoonpong, Gompol Suwanpimolkul, Watsamon Jantarabenjakul, Nattachai Srisawat, Monvasi Pachinburavan ; DOI: 10.1002/rcr2.733
First published 7 March 2021
Alistair G B Broadhurst, Usha Lalla, Jantjie J Taljaard, Elizabeth H Louw, Coenraad F N Koegelenberg, Brian W Allwood; DOI: 10.1002/rcr2.725
First published 22 February 2021
Kuniko Takahashi, Koichiro Kajiura, Michitaka Nasu, Kei Nakamura, Kazuki Sugata, Akiko Matsuzaki; DOI: 10.1002/rcr2.724
First published 22 February 2021
Akiko Maeda; Daijiro Nabeya; Hiroaki Nagano; Nobuhito Yagi; Tadayoshi Miyagi; Tomoo Kishaba; DOI: 10.1002/rcr2.700
First published 15 December 2020
Atsushi Kitamura, Clara So, Torahiko Jinta; DOI: 10.1002/rcr2.689
First published 29 November 2020
Koutaro Murao, Atsushi Saito, Koji Kuronuma, Yoshihiro Fujiya, Satoshi Takahashi, Hirofumi Chiba; DOI: 10.1002/rcr2.683
First published 16 November 2020
Mayuko Ishiwari, Yuki Togashi, Hiroyuki Takoi, Ryota Kikuchi, Yuta Kono, Shinji Abe; DOI: 10.1002/rcr2.679
First published 1 November 2020
Amy O'Brien, James Campling, Hugh Goodman, Catherina L Chang; DOI: 10.1002/rcr2.650
First published 25 August 2020
Samantha Herath, Natalie Kruit, Adam Eslick, Nicole Giroy; DOI: 10.1002/rcr2.631
First published 28 July 2020
Yuto Akiyama, Kohei Horiuchi, Yasushi Kondo, Hiroki Kabata, Makoto Ishii, Koichi Fukunaga
DOI: 10.1002/rcr2.622
First published 15 July 2020
Boon Hau Ng, Nik Nuratiqah Nik Abeed, Mohamed Faisal Abdul Hamid, Chun Ian Soo, Hsueh Jing Low, Yu-Lin Andrea Ban
DOI: 10.1002/rcr2.604
First published 25 June 2020
Clara So, Shosei Ro, Manabu Murakami, Ryosuke Imai, Torahiko Jinta
DOI: 10.1002/rcr2.596
First published 4 June 2020
Ari J Ciment, Lawrence M Ciment
DOI: 10.1002/rcr2.591
First published 21 May 2020
A collection of cases on COVID-19 and earlier coronaviruses can be read here
Online
Advertise your event here!
to hide list)
from Tokyo
17:00 (UTC+9), Wednesday, 14 June 2023
Details will be uploaded to webinar.apsr.info/webinar-20230614 when confirmed.
from Tokyo
Tuesday 25 October 2022
Details will be uploaded to webinar.apsr.info when confirmed.
from Australia
Friday 19 July 2022
apsresp.org/archive/webinar/20220719.html
Post-webinar video available until 31 October 2022
apsresp.org/archive/webinar/20220719.php
Lung Diseases and COVID-19 Online Congress for the Public
The Turkish Thoracic Society invite you to watch their second "Lung Diseases and COVID-19 Online Congress for the Public". This will take place on 26-27 February 2022, 12:00-18:00 (Turkish time, UTC+3). There will be a total of 24 sessions, each lasting for half an hour.
Within the scope of this congress; the community (including our patients and/or their relatives) will have the opportunity to access the most up-to-date and accurate information about lung diseases and COVID, as well as to ask live questions. It can be nice chance actually for people with concerns about applying to the hospitals due to the pandemic.
The programme below summarizes the rich content of the congress, which will be discussed mainly by specialists on topics and aired live in Turkish via the Turkish Thoracic Society's social media accounts (YouTube, Facebook, and Instagram). Additionally, you can follow this congress with simultaneous English translation via another YouTube channel "Turkish Thoracic Society” at youtube.com/channel/UCKTRq9lVwM-oTD2rOW1B7rQ).
Programme
(All times are UTC+3)
26 February 2022
| 12:00-12:25 | Opening session: Why do we need to plan a congress for the public? Oya Itil, Benan Müsellim, Füsun Topçu |
| 12:30-12:55 | Should I have a check-up for lung diseases? Çağla Uyanusta Küçük, Osman Elbek |
| 13:00-13:25 | Why am I coughing for so long? Elif Şen, Ali Fuat Kalyoncu |
| 13:30-13:55 | I'm unable to quit smoking; am I frail? Seren Arpaz, Oğuz Kılınç |
| 14:00-14:25 | Electronic cigarette: Being caught in hail while escaping the rain Aslı Görek Dilektaşlı, Elif Dağlı |
| 14:30-14:55 | There is no miracle cure for COPD Sibel Naycı, Cantürk Taşçı |
| 15:00-15:25 | Why are my inhaler medications not working? (Patient usage mistakes) Ebru Damadoğlu, Feride Taşkın Yılmaz |
| 15:30-15:55 | Respiratory rehabilitation in chronic lung diseases Pınar Ergün, İpek Candemir |
| 16:00-16:25 | Is tuberculosis still around in this day and age? Şeref Özkara, Aylin Babalık |
| 16:30-16:55 | Should I be concerned about a lung nodule? Sevin Başer Öncel, Pınar Çelik |
| 17:00-17:25 | Does my obsession with hygiene makes me a patient with pulmonary disease? Neşe Direk, Bilun Gemicioğlu |
| 17:30-17:55 | Snoring can be a sign of a serious medical condition Çağlar Çuhadaroğlu, Baran Balcan |
| 18:00-18:25 | Who is eligible for a lung transplant? Özlem Özdemir Kumbasar, Erdal Yekeler |
27 February 2022
| 12:00-12.25 | Why Is the pandemic not ending? Is this our fate? Oya İtil, Osman Elbek |
| 12:30-12:55 | What is the impact of the climate crisis and air pollution on our health? Ali Kocabaş, Cavit Işık Yavuz |
| 13:00-13:25 | Myths and truths about the Covid-19 vaccine Cüneyt Saltürk |
| 13:30-13:55 | What concerns you about the COVID, influenza, and pneumonia vaccines? Füsun Eyüboğlu, Abdullah Sayıner |
| 14:00-14:25 | Should I vaccinate my child with Covid-19 vaccine? Elif Dağlı, Mehmet Ceyhan |
| 14:30-14:55 | What to do while staying at home with COVID? What should you pay attention to? Göksel Altınışık Ergur, Öner Dikensoy |
| 15:00-15:25 | I had COVID, when will my shortness of breath improve? Oğuz Uzun, Serap Argun, Züleyha Bingöl |
| 15:30-15:55 | Your inquiries regarding Covid-19 and the risk of blood clots Aslıhan Gürün Kaya, Serhat Erol |
| 16:00-16:25 | My relative with COVID is in intensive care unit Özlem Ediboğlu, Nalan Adıgüzel |
| 16:30-16:55 | Precautions against COVID in the workplaces Peri Arbak, Haluk Çalışır |
| 17:00-17:25 | All aspects of Covid-19 in patients with asthma and allergy Dilşad Mungan, Kıvılcım Oğuz Özülgen |
| 17:30-17:55 | The pandemic-related deaths of healthcare personnel Pınar Bostan |
| 18:00-18:30 | Closing Session |
Turkish Thoracic Society: toraks.org.tr
from Singapore
Friday 15 October 2021
apsresp.org/archive/webinar/20211015.html
Post-webinar video available until 31 January 2022 (APSR members only)
apsresp.org/archive/webinar/20211015.php
at NAPCON
Thursday 28 January 2021
apsresp.org/archive/covid-19/napcon-20210128.php
See also the post-conference report
at the 2020 Annual Congress of Taiwan Society of Pulmonary and Critical Care Medicine
12 December 2020
apsresp.org/education/joint-symposium/202012-tspccm.php
Asia-Pacific expert panel
15-17 July 2020
apsresp.org/archive/covid-19/rajavithi-webinar-20200715.html
Asia-Pacific expert panel
Wednesday 29 April 2020
apsresp.org/archive/webinar/20200429.html
Asia-Pacific expert panel
Wednesday 22 April 2020
apsresp.org/archive/webinar/20200422.html
Fri/Sat 27 March 2020
apsresp.org/archive/webinar/20200327.html
of some of the above webinars can be heard at anchor.fm/apsr. See also the webinar pages for their image slides, YouTube videos and post-webinar Q&A.
